(Q44704125)

5 December 2017

title

Studies of the potential utility of Ki67 as a predictive molecular marker of clinical response in primary breast cancer (English)

1 reference

5 December 2017

Assersohn L

1

1 reference

5 December 2017

Salter J

2

1 reference

5 December 2017

Powles TJ

3

1 reference

5 December 2017

A'hern R

4

1 reference

5 December 2017

Makris A

5

1 reference

5 December 2017

Gregory RK

6

1 reference

5 December 2017

Chang J

7

1 reference

5 December 2017

Dowsett M

8

1 reference

5 December 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

Breast Cancer Research and Treatment

5 December 2017

published in

1 reference

5 December 2017

volume

82

1 reference

5 December 2017

issue

2

1 reference

5 December 2017

page(s)

113-123

1 reference

Effect of tamoxifen on Ki67 labelling index in human breast tumours and its relationship to oestrogen and progesterone receptor status.

5 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003968.45511.3F

Primary chemotherapy in breast invasive carcinoma: predictive value of the immunohistochemical detection of hormonal receptors, p53, c-erbB-2, MiB1, pS2 and GST pi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003968.45511.3F

Prognostic role of clinical, pathological and biological characteristics in patients with locally advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003968.45511.3F

Assessment of response to therapy in advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003968.45511.3F

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003968.45511.3F

7 January 2021

Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Institut Bergonié Bordeaux Groupe Sein (IBBGS)

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003968.45511.3F

7 January 2021

A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003968.45511.3F

7 January 2021

Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003968.45511.3F

7 January 2021

The relationship between prognostic and predictive factors in the management of breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003968.45511.3F

7 January 2021

Long term prognostic value of growth fraction determination by Ki-67 immunostaining in primary operable breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003968.45511.3F

7 January 2021

Ki-67, p53, Er-receptors, ploidy and S-phase as prognostic factors in T1 node negative breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003968.45511.3F

7 January 2021

Reduced apoptosis and proliferation and increased Bcl-2 in residual breast cancer following preoperative chemotherapy

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003968.45511.3F

7 January 2021

Changes in hormone receptors and proliferation markers in tamoxifen treated breast cancer patients and the relationship with response

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003968.45511.3F

7 January 2021

A pilot study of the effects of short-term tamoxifen therapy on Ki-67 labelling index in women with primary breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003968.45511.3F

7 January 2021

Biologic markers as predictors of clinical outcome from systemic therapy for primary operable breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003968.45511.3F

7 January 2021

Quantitative changes in cytological molecular markers during primary medical treatment of breast cancer: a pilot study

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003968.45511.3F

7 January 2021

Randomized trial of chemoendocrine therapy started before or after surgery for treatment of primary breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003968.45511.3F

7 January 2021

MIB-1 assessments in breast cancers

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003968.45511.3F

7 January 2021

Comparison of the results of immunocytochemical assays for biologic variables on preoperative fine-needle aspirates and on surgical specimens of primary breast carcinomas

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003968.45511.3F

7 January 2021

Change in expression of ER, bcl-2 and MIB1 on primary tamoxifen and relation to response in ER positive breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003968.45511.3F

7 January 2021

Methodological challenges in the evaluation of prognostic factors in breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003968.45511.3F

7 January 2021

Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003968.45511.3F

7 January 2021

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003968.45511.3F

7 January 2021

Molecular portraits of human breast tumours

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003968.45511.3F

7 January 2021

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

1 reference

https://api.crossref.org/works/10.1023%2FB%3ABREA.0000003968.45511.3F

7 January 2021

10.1023/B:BREA.0000003968.45511.3F

Identifiers

DOI

1 reference

Dimensions Publication ID

5 December 2017

1022107957

0 references

1 reference